Adaptimmune Therapeutics PLC Sponsored ADR is a company in the U.S. stock market and it is a holding in 6 U.S.-traded ETFs. ADAP has around 1.3M shares in the U.S. ETF market. The largest ETF holder of ADAP is the iShares Biotechnology ETF (IBB), with approximately 840.52K shares. Investors may also find of interest that the ETF with the largest allocation to ADAP stock is Simplify Propel Opportunities ETF (SURI), with a portfolio weight of 0.27%. On average, U.S. ETFs allocate 0.05% of ADAP to their portfolios.